SCHEMBL25753493

SCHEMBL25753493

CC(C)(C)NC(=O)c1ccc(N2CCCCC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.63
MAPT P10636 12/20 0.56
RAB9A P51151 8/20 0.56
NPC1 O15118 7/20 0.56
SMN1; SMN2 Q16637 6/20 0.56
KMT2A Q03164 6/20 0.56
KDM4E B2RXH2 4/20 0.56
MCL1 Q07820 2/20 0.56
LMNA P02545 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
MEN1 O00255 2/20 0.56
TP53 P04637 4/20 0.55
ALOX15 P16050 4/20 0.55
MAPK1 P28482 2/20 0.55
HTT P42858 1/20 0.55
PKM P14618 1/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
USP2 O75604 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15448546 0.86 HDAC3 (0.61) RAB9ANPC1SMN1; SMN2KMT2ALMNA
SCHEMBL13701825 0.86 MAPT (0.64) HDAC6MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL7956169 0.83 SLC2A1 (0.51) HDAC6MAPTSMN1; SMN2TP53MAPK1
SCHEMBL13701687 0.82 MEN1 (0.59) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL13701660 0.80 MEN1 (0.60) MAPTRAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL26398689 0.80 HDAC6 (0.71) HDAC6MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL6125266 0.79 HDAC6 (0.65) HDAC6MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL17865779 0.78 LMNA (0.58) MAPTSMN1; SMN2LMNAHTT
SCHEMBL26054700 0.78 MAPT (0.57) HDAC6MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL7337653 0.78 HDAC6 (0.69) HDAC6MAPTRAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240026358-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2024-01-25 US disclosed
US-20230203484-A1 DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO WAVE LIFE SCIENCES LTD. (SG) 2023-06-29 US disclosed
US-20230203087-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203087-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF RNGTT, NSUN2, ALKBH1 HDAC6 3239/4885MAPT 4649/4885RAB9A 4490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.